Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- The Future of Fatty Liver: From Education to Anticipated Approvals
-
- 7 Things you Need to Know for C. difficile Awareness Month
- NAFLD Treatment Achieves Liver Fat Reduction in Phase 2 Trial
- New Device Successful in Slim Colonoscopy Procedures
- Therapeutic Improves Liver Function, Insulin Resistance in NASH Phase 2B Trial
- Weeding out the ‘Good’ and ‘Bad’ of Probiotics for our Patients
- Antibiotic, Acid Suppression Medications Linked to Obesity in Children
- Appendix Removal Tied to Decreased Parkinson’s Risk
- Continuing Clopidogrel Does not Increase Bleeding Risk After Polypectomy
-
- Humira Levels Linked to Biologic Crohn’s Remission
- Initiating Treatment With Most PPIs Linked to Hyponatremia
- Longer Breastfeeding Duration Lowers Women’s Risk for NAFLD
- More Conflict Guidance Needed for GI Guideline Authors, Study Finds
- Navigators Could Improve Follow-Up Rates After Positive Fecal Blood Tests
- AI System Meets ‘Resect and Discard’ Polyp Identification Standards
- Aramchol Reduces Liver Fat, Improves Histology in NASH
- Cannabis Oil Improves Crohn’s Symptoms, QOL
-
- Crohn’s & Colitis Congress: Offering Physicians ‘a new way’ to View IBD
- Fatty Liver Imposes 91% Higher Risk for Cancer
- NGM282 Shows Equivalent Efficacy in NASH at Lower Dose
- Subcutaneous Vedolizumab Shows Promise for Ulcerative Colitis
- Vibrating Capsule Effective for Chronic Idiopathic Constipation
- #StolenColon Goes Viral, Raises more than $11,000 for CRC Awareness
- FDA Allows for Expanded Marketing of 23andMe to Include Medication Metabolism